MedPacto, Inc. (KOSDAQ:235980)
2,980.00
-130.00 (-4.18%)
Apr 2, 2025, 3:30 PM KST
MedPacto Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 15,009 | 72,604 | 359.85 | 1,293 | 2,692 |
Short-Term Investments | 40,469 | - | 96,594 | 120,280 | 42,611 |
Cash & Short-Term Investments | 55,479 | 72,604 | 96,954 | 121,573 | 45,303 |
Cash Growth | -23.59% | -25.11% | -20.25% | 168.36% | - |
Accounts Receivable | -0 | 0 | 0 | 0 | 0 |
Other Receivables | 382.62 | 844.27 | 1,799 | 393.13 | 310.78 |
Receivables | 382.62 | 844.27 | 1,799 | 393.13 | 310.78 |
Prepaid Expenses | 50.37 | 99.2 | 351.64 | 381.67 | 425.04 |
Other Current Assets | 878.26 | 1,607 | 1,226 | 3,738 | 2,985 |
Total Current Assets | 56,790 | 75,154 | 100,331 | 126,085 | 49,024 |
Property, Plant & Equipment | 2,789 | 3,647 | 5,203 | 2,563 | 3,317 |
Long-Term Investments | 224.28 | 626.12 | 994.75 | 3,384 | 5,230 |
Other Intangible Assets | 228.37 | 343.13 | 438.24 | 565.62 | 564.78 |
Long-Term Accounts Receivable | -0 | 0 | 0 | 0 | -0 |
Other Long-Term Assets | 753.59 | 704.17 | 719.86 | 747.06 | 361.15 |
Total Assets | 60,785 | 80,474 | 107,687 | 133,346 | 58,496 |
Accrued Expenses | 190.98 | 182.83 | 237.49 | 230.18 | 182.23 |
Short-Term Debt | - | - | 60,264 | - | - |
Current Portion of Leases | 460.78 | 740.54 | 689.06 | 190.17 | 439.71 |
Other Current Liabilities | 723.61 | 641.5 | 5,432 | 557.4 | 1,842 |
Total Current Liabilities | 1,375 | 1,565 | 66,623 | 977.75 | 2,464 |
Long-Term Debt | - | - | - | 75,413 | - |
Long-Term Leases | 1,480 | 1,687 | 2,423 | - | - |
Other Long-Term Liabilities | 186.55 | 137.28 | 142.18 | 13,413 | 289.63 |
Total Liabilities | 3,042 | 3,389 | 69,188 | 89,803 | 2,753 |
Common Stock | 17,138 | 16,790 | 10,540 | 10,258 | 10,171 |
Additional Paid-In Capital | 239,555 | 233,030 | 165,396 | 141,372 | 136,739 |
Retained Earnings | -199,294 | -179,154 | -143,829 | -108,076 | -91,036 |
Comprehensive Income & Other | 345.38 | 242.42 | 215.57 | -11.16 | -131.29 |
Total Common Equity | 57,743 | 70,909 | 32,323 | 43,543 | 55,743 |
Shareholders' Equity | 57,743 | 77,085 | 38,499 | 43,543 | 55,743 |
Total Liabilities & Equity | 60,785 | 80,474 | 107,687 | 133,346 | 58,496 |
Total Debt | 1,941 | 2,427 | 63,377 | 75,603 | 439.71 |
Net Cash (Debt) | 53,538 | 70,177 | 33,577 | 45,970 | 44,863 |
Net Cash Growth | -23.71% | 109.00% | -26.96% | 2.47% | - |
Net Cash Per Share | 1589.63 | 3307.71 | 1009.58 | 2245.36 | 2210.64 |
Filing Date Shares Outstanding | 34.28 | 33.58 | 21.08 | 20.52 | 20.34 |
Total Common Shares Outstanding | 34.28 | 33.58 | 21.08 | 20.52 | 20.34 |
Working Capital | 55,415 | 73,589 | 33,708 | 125,108 | 46,560 |
Book Value Per Share | 1684.70 | 2111.59 | 1533.28 | 2122.33 | 2740.17 |
Tangible Book Value | 57,515 | 70,566 | 31,884 | 42,977 | 55,178 |
Tangible Book Value Per Share | 1678.04 | 2101.37 | 1512.49 | 2094.77 | 2712.41 |
Machinery | 1,053 | 1,244 | 3,799 | 2,914 | 2,241 |
Construction In Progress | - | - | - | - | 18 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.